Navigation Links
North Shore-LIJ Health System's Feinstein Institute to Receive $250,000 Grant from Lymphoma Research Foundation Grant to support research of Chronic Lymphocytic Leukemia
Date:7/25/2013

MANHASSET, NY (PRWEB) July 25, 2013

The Feinstein Institute for Medical Research announced today it will receive a $250,000 grant aimed at gaining a better understanding of chronic lymphocytic leukemia (CLL) and other blood cancers.

The two-year grant from the Lymphoma Research Foundation (LRF), the nation’s largest non-profit organization devoted to funding innovative lymphoma research, was awarded to
Nicholas Chiorazzi, MD, head of the Karches Center for Chronic Lymphocytic Leukemia Research at the Feinstein Institute. Dr. Chiorazzi’s lab and that of his collaborator, Dr. Matthew D. Scharff at the Albert Einstein College of Medicine in the Bronx, will utilize the funds to research gene expression and DNA methylation signatures linked to in vivo CLL/small lymphocytic lymphoma B-cell kinetics and outcome.

“I am grateful to the Lymphoma Research Foundation for supporting this research so that Dr. Scharff and I can work to better understand CLL and ultimately find a new, improved treatment for the devastating disease,” said Dr. Chiorazzi.

The grant received from LRF is a portion of a $2.15 million grant divided among seven scientists investigating the biology of or new therapies for lymphoma.

“As evident in our recent funding of more than $2 million in research, the Lymphoma Research Foundation is dedicated to finding a cure for lymphoma through an aggressively funded research program,” said Diane Blum, LRF chief executive officer. “We remain grateful to our supporters whose generosity enables the Foundation to work toward its mission of eradicating lymphoma through innovative research.”

Recommendations for research funding were made by the LRF Scientific Advisory Board, which is comprised of the world’s leading lymphoma researchers and oncologists. The award recommendations were then approved by the LRF Board of Directors.
Grantees include:

About the Lymphoma Research Foundation
The Lymphoma Research Foundation (LRF) is the nation’s largest non-profit organization devoted to funding innovative research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives and patient services. To date, LRF has awarded more than $54 million in lymphoma-specific research. For additional information on LRF’s research, education and services, please visit lymphoma.org.

About The Feinstein Institute for Medical Research
Headquartered in Manhasset, NY, The Feinstein Institute for Medical Research is home to international scientific leaders in many areas including Parkinson's disease, Alzheimer’s disease, psychiatric disorders, rheumatoid arthritis, lupus, sepsis, human genetics, pulmonary hypertension, leukemia, neuroimmunology, and medicinal chemistry. The Feinstein Institute, part of the North Shore-LIJ Health System, ranks in the top 5th percentile of all National Institutes of Health grants awarded to research centers. For more information, visit http://www.FeinsteinInstitute.org.

Read the full story at http://www.prweb.com/releases/2013/7/prweb10965090.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Keeping Kids Safe: North Shore-LIJ Trains Nassau Police and Youth Explorers in Car Seat Safety
2. Hofstra North Shore-LIJ Medical Scholars Pipeline Program Serves Up a Summer of Enriching Experiences to 61 High School Students
3. Best 2013 Charlotte, North Carolina Security System Companies Rated by 6Webs.com
4. Worldwide Power Products Announces Strategic Partnership with Northstar Recovery Services; Attains Registered Vendor Status
5. Hollywood Comes to Thomasville North Carolina’s Favorite Restaurant -Southern Sisters
6. Three North Shore-LIJ Health System Hospitals Called Leaders in LGBT Equality
7. HCT Packaging, Inc. to Present Cutting Edge Packaging Innovations at CosmoProf North America 2013
8. Long Island Bike Challenge Rides to Raise Money for North Shore-LIJ's Feinstein Institute of Medical Research
9. Westchester County Surgery Team Performs Region's First Robot-Assisted Splenectomy at Northern Westchester Hospital
10. Katz Women’s Hospital at North Shore Earns LEED Platinum Green Building Certification for Second Time
11. North America Market for Obesity Management & Weight Loss 2017 Forecasts in New Research Report at RnRMarketResearch.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... ... Advanced Surgical, Inc. is thrilled to offer the recently FDA-approved Obalon Balloon System ... procedure adds to SkyLex Advanced Surgical’s already comprehensive list of weight-loss services. ...
(Date:3/28/2017)... ... , ... Oily skin is a common and unwelcomed occurrence in people of all ages, genders ... offer to the discussion of dealing with excess skin oil. “Oily skin is a challenge ... that can help remove the oily shine while keeping the skin fresh and clean,” says ...
(Date:3/27/2017)... ... March 27, 2017 , ... New patients who have ... sleep apnea treatment, with or without a referral. Sleep apnea is often left untreated ... daytime sleepiness, morning headaches and chronic snoring. , Dr. Braasch seeks to raise ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... gain site attention and engagement over the household brands of Top-20 pharma by ... will discuss how partnering with the right outsourcing payments provider can provide the ...
(Date:3/27/2017)... ... 27, 2017 , ... Adding to its expanding portfolio of ... and NEJM Journal Watch, announces the release of NEJM Knowledge+ Pediatrics Board ... of pediatricians from leading medical centers. The content was then reviewed and approved ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... Elysium Health joins major pharmaceutical ... Cambridge academic scientists through ... Milner Therapeutics Institute today announces Elysium Health as a partner ... investment for collaborative projects with academic researchers in ... the first major research investment outside the U.S. for the ...
(Date:3/27/2017)... 2017 Therapix Biosciences Ltd. ... in the development of cannabinoid-based drugs, today announced ... the United States of 2,000,000 ... ordinary shares of the Company, at a price ... granted the underwriters a 45-day over-allotment option to ...
(Date:3/27/2017)... VANCOUVER, British Columbia , March 27, 2017 /PRNewswire/ ... of Directors has appointed William "Bill" Dubiel as President ... Dubiel was also elected to the Board of Directors ... serve as the Executive Chairman of LightIntegra. ... become LightIntegra,s next President and Chief Executive Officer. We,ve ...
Breaking Medicine Technology: